Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

SEC alleges largest-ever insider-trading scheme
Marketwatch
Tuesday, November 20, 2012 - 1:13pm
tags:
SEC, insider trading, Elan, Pfizer, Wyeth
Nestle Purchase of Pfizer Unit Blocked in Mexico
Bloomberg
Tuesday, November 20, 2012 - 1:12pm
tags:
Nestle, Pfizer, Mexico, M&A, infant nutrition
Aeterna Zentaris: Late-Stage Drug Candidates Could Send Stock Higher
Seeking Alpha
Tuesday, November 20, 2012 - 11:36am
tags:
Aeterna Zentaris, AEZS-108, perifosine, AEZS-130
Sarepta Ready To Move Higher
Seeking Alpha
Tuesday, November 20, 2012 - 11:35am
tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
Alexza Pharma: Run-Up Trade Into December's Approval Decisions
TheStreet.com
Tuesday, November 20, 2012 - 11:32am
tags:
Alexza, FDA, Adasuve, antipsychotics
Testosterone, Viagra not a winning ED combination
Reuters
Tuesday, November 20, 2012 - 11:31am
tags:
Pfizer, erectile dysfunction, testosterone, Viagra
Takeda Consultant Loses Two Whistleblower Suits
Pharmalot
Tuesday, November 20, 2012 - 11:29am
tags:
Takeda, whistleblower lawsuits
Novo Nordisk A/S: Catching The Increasing Diabetes Trend
Seeking Alpha
Tuesday, November 20, 2012 - 11:27am
tags:
diabetes, Novo Nordisk, Bristol-Myers Squibb, Eli Lilly, Sanofi
FDA Approval Victory a Yawner?
Motley Fool
Tuesday, November 20, 2012 - 11:24am
tags:
FDA, GSK, Ligand, Promacta, hepatitis C
Reckitt set to win Schiff as Bayer quits $1.4 bln fight
Reuters
Tuesday, November 20, 2012 - 11:22am
tags:
Schiff, Bayer AG, M&A, Reckitt Benckiser
The 3 Biggest Risks Facing GlaxoSmithKline
Motley Fool
Tuesday, November 20, 2012 - 11:21am
tags:
GSK
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
TheStreet.com
Monday, November 19, 2012 - 2:00pm
tags:
Oncothyreon, Celsion, Arena Pharmaceuticals, NuPathe, Hemispherx, Amarin, Biogen Idec, Gilead, Hyperion Therapeutics, Celgene, Raptor Pharmaceuticals, Dynavax, Zogenix, Impax Labs
Illumina reveals bid for Complete Genomics
Markewatch
Monday, November 19, 2012 - 1:57pm
tags:
M&A, Illumina, Complete Genomics
Celgene's Lazorchak, Five Others, Charged With Insider Trading
Yahoo/Bloomberg
Monday, November 19, 2012 - 1:55pm
tags:
insider trading, Celgene
3 Things to Watch With Nektar Therapeutics
Motley Fool
Monday, November 19, 2012 - 1:55pm
tags:
Nektar, Naloxegol, AstraZeneca
Is This Biotech Fishing for a Higher Bid?
Motley Fool
Monday, November 19, 2012 - 1:26pm
tags:
Geron, BioTime, M&A
Picking The Weight Loss Winner In The Arena Vs. Vivus War
Seeking Alpha
Monday, November 19, 2012 - 11:16am
tags:
Arena Pharmaceuticals, Vivus, Belviq, Qsymia
5 Healthcare Companies With Recent Insider Buying
Seeking Alpha
Monday, November 19, 2012 - 11:15am
tags:
Synergy Pharmaceuticals, Progenics, Pacific Biosciences, MAKO, insider trading, Celsion
A Garage Sale for MannKind
Motley Fool
Monday, November 19, 2012 - 11:09am
tags:
MannKind, MKC1106
Alexza receives updated day 180 list of outstanding issues for Adasuve
The Fly on the Wall
Monday, November 19, 2012 - 11:08am
tags:
Alexaza, Adasuve, Europe

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.